A Clinical Study of MIL62 in Primary Membranous Nephropathy

Condition:   Primary Membranous Nephropathy Interventions:   Drug: MIL62;   Drug: Cyclosporine Sponsor:   Beijing Mabworks Biotech Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials